HCV-related mortality among male prison inmates in Texas, 1994-2003

Annals of Epidemiology

Volumn 19, Issue 8, 2009, Pages 582-589

  Harzke, Amy J ^a   Baillargeon, Jacques G ^a   Kelley, Michael F ^b   Diamond, Pamela M ^d   Goodman, Karen J ^c   Paar, David P ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Office of Preventive Medicine   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hepatitis; Liver Diseases; Mortality; Prisoners; Prisons

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC LIVER DISEASE; ETHNIC DIFFERENCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PRISONER; RACE DIFFERENCE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRISONS; TEXAS;

EID: 67649370760     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.03.009     Document Type: Article

References (62)

1. Centers for Disease Control and Prevention. Disease burden from hepatitis A, B, and C in the United States. Available at: http://www.cdc.gov/hepatitis/Statistics.htm#section3.
2. Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., and Alter M.J. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 (2006) 705-714
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 47 RR-19 (1998) 1-39
4. McGlynn K.A., Tsao L., Hsing A.W., Devesa S.S., and Fraumeni J.F. International trends and patterns of primary liver cancer. Int J Cancer 94 (2001) 290-296
5. World Health Organization. Hepatitis C: global prevalence update. Wkly Epidemiol Rec 72 (1997) 341-348
6. Ruiz J.D., Molitor F., Sun R.K., Mikanda J., Facer M., Colford J.M., et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med 170 (1999) 156-160
7. Ruiz J.D., Moliter F., and Plagenhoef J.A. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS 16 (2002) 2236-2238
8. Fennie K.P. HCV seroprevalence and seroincidence in Connecticut's sole correctional facility for women. [Ph.D. dissertation] (2003), Yale University, New Haven, CT
9. Macalino G.E., Vlahov D., Dickinson B.P., Schwartzapfel B., and Rich J.D. Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis 41 (2005) 998-1002
10. Macalino GE, Rich JD, Sandford-Colby S, Salas CM, Vlahov D. Intake prevalence and intraprison incidence of HIV, hepatitis B (HBV), and hepatitis C (HCV) among sentenced inmates in Rhode Island, USA. International Conference on AIDS; Abstract 9208; Barcelona, Spain, July 7-12, 2002.
11. Macalino G.E., Vlahov D., Sandford-Colby S., Patel S., Sabin K., Salas C., et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 94 (2004) 1218-1223
12. Baillargeon J., Wu H., Kelley M.F., Grady J., Linthicum L., and Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health 117 (2003) 43-48
13. Fox R.K., Currie S.L., Evans J., Wright T.L., Tobler L., Phelps B., et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 41 (2005) 177-186
14. Solomon L., Flynn C., Muck K., and Vertefeuille J. Prevalence of HIV, syphilis, Hepatitis B, and Hepatitis C among entrants to Maryland correctional facilities. J Urban Health 81 (2004) 25-37
15. Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR 52 No. RR-1 (2003)
16. Spaulding A., Greene C., and Davidson K. Schneidermann, Rich J. Hepatitis C in state correctional facilities. Prev Med 28 (1999) 99-100
17. Baillargeon J., Soloway R.D., Paar D., Giordano T.P., Murray O., Grady J., et al. End-stage liver disease in a state prison population. Ann Epidemiol 17 (2007) 808-813
18. Baillargeon J, Snyder N, Paar D, Baillargeon G, Spaulding A, Pollock BH, et al. Hepatocellular carcinoma prevalence and mortality in a male state prison population. Public Health Rep. 209;124:120-126.
19. Mitka M. Aging prisoners stressing health care system. JAMA 292 (2004) 423-424
20. Harrison PM, Beck AJ. Prisoners in 2002, Bureau of Justice Statistics Bulletin (NCJ 200248). Washington, DC: US Department of Justice; 2003. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/p02.pdf.
21. West HC, Sabol WJ. Prisoners in 2007. Bureau of Justice Statistics Bulletin (NCJ 224280). Washington, DC: US Department of Justice; 2008. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/p07.pdf.
22. Beck AJ, Mumola CJ. Prisoners in 1998. Bureau of Justice Statistic Bulletin (NCJ 175687). Washington, DC: Department of Justice; 1999. Available at: http://www.ojp.usdoj.gov/bjs/pub/pdf/p98.pdf.
23. One in 100 Behind Bars in America, 2008. Washington, DC: Pew Center on the States; 2008. Available at: http://www.pewcenteronthestates.org/report_detail.aspx?id=35904.
24. National Center for Health Statistics/Centers for Disease Control and Prevention. Instructions for classifying the underlying cause-of-death. Hyattsville (MD): U.S. Department of Health and Human Services, 2008. Available at: http://www.cdc.gov/nchs/data/dvs/2a2008Final.pdf.
25. Shojania K.G., Burton E.C., McDonald K.M., et al. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA 289 (2003) 2849-2856
26. Vong S., and Bell B.P. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 39 (2004) 476-483
27. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio. Am J Epidemiol 131 (1990) 373-375
28. National Cancer Institute/Statistical Research and Applications. Joinpoint Regression Program (version 3.3): Average annual percent change. Available at: http://srab.cancer.gov/joinpoint/aapc.html.
29. Beck A.J. Prisoners in 1999. Bureau of Justice Statistics Bulletin (NCJ 183476) (2000), US Department of Justice, Washington, DC
30. Census 2000 Gateway. 100% Demographic Profile by State. Washington, DC: US Census Bureau; 2004. Available at http://www.census.gov/main/www/cen2000.html.
31. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. International Agency for Research on Cancer. Lyon, France. IARC Sci publ. 1994;128:1-302.
32. Sahai H., and Khurshid A. Statistics in Epidemiology: Methods, Techniques, and Applications (1996), CRC Press, Boca Raton (FL)
33. Stata Corporation. Stata (v. 8.2), Data Analysis and Statistical Software (2002), Stata Corporation, College Station (TX)
34. StatsDirect Statistical Software, Version 2.7.2 (2008), StatsDirect Ltd, Cheshire, WA, UK
35. National Cancer Institute/Statistical Research and Applications. Joinpoint Regression Program, version 3.3; 2008. Available at: http://srab.cancer.gov/joinpoint.
36. Singh G.K., Miller B.A., and Hankey B.F. Changing areas socioeconomic patterns in U.S. cancer mortality, 1950-1998. Part II-Lung and colorectal cancers. J Natl Cancer Inst 94 (2002) 916-925
37. Weir H.K., Thun M.J., Hankey B.F., Ries L.A., Howe H.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95 (2003) 1276-1299
38. U.S. Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Office of Analysis and Epidemiology (OAE), Compressed Mortality File (CMF) compiled from CMF 1968-1988, Series 20, No. 2A 2000, CMF 1989-1998, Series 20, No. 2E 2003 and CMF 1999-2003, Series 20, No. 2I 2006 on CDC WONDER On-line Database. Available at: http://wonder.cdc.gov.
39. Fazel S., Bains P., and Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 101 (2006) 181-191
40. McClellan D.S., Farabee D., and Crouch B.M. Early victimization, drug use, and criminality: a comparison of male and female prisoners. Crim Justice Behav 24 (1997) 455-476
41. Hellard M.E., Aitken C.K., and Hocking J.S. Tattooing in prison-not such a pretty picture. Am J Infect Control 35 (2007) 477-480
42. Vescio M.F., Longo B., Babudieri S., Starnini G., Carbonara S., Rezza G., et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health 62 (2008) 305-313
43. Samuel M.C., Doherty P.M., Bulterys M., and Jenison S.A. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect (2001) 475-484
44. Hand W.L., and Vasquez Y. Risk factors for hepatitis C on the Texas-Mexico border. Am J Gastroenterol 100 (2005) 2180-2185
45. Steuve A., and O'Donnell L.N. Early alcohol initiation and subsequent sexual and alcohol risk behaviors among urban youths. Am J Public Health 95 (2005) 887-893
46. Delva J., Wallace J.M., O'Malley P.M., Bachman J.G., Johnston L.D., and Schulenberg J.E. The epidemiology of alcohol, marijuana, and cocaine use among Mexican American, Puerto Rican, Cuban American, and other Latin American eighth-grade student in the United States: 1991-2002. Am J Public Health 95 (2005) 696-702
47. Cheung R.C., Currie S., Shen H., Ho S.B., Bini E.J., Anand B.S., et al. Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. Am J Gastroenterol 100 (2005) 2186-2193
48. Caetano R. Alcohol use among Hispanic groups in the United States. Am J Drug Alcohol Abuse 14 (1988) 293-308
49. Randolph W.M., Stroup-Benham C., Black S.A., and Markides K.S. Alcohol use among Cuban-Americans, Mexican-Americans, and Puerto Ricans. Alcohol Health Res World 22 (1998) 265-269
50. Nielsen A.L. Examining drinking patterns and problems among Hispanic groups: results from a national survey. J Stud Alcohol 61 (2000) 301-310
51. Flores Y.N., Yee Jr. H.F., Leng M., Escarce J.J., Bastani R., Salmerón J., et al. Risk factors for chronic liver disease in blacks, Mexican-Americans, and whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol 103 (2008) 2231-2238
52. Meltzer A.A., and Everhart J.E. Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. Am J Epidemiol 146 (1997) 565-571
53. Arya R., Duggirala R., Almasy L., Rainwater D.L., Mahaney M.C., Cole S., et al. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nat Genet 30 (2002) 102-105
54. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
55. Di Bisceglie A.M., Lyra A.C., Schwartz M., Reddy R.K., Martin P., Gores G., et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98 (2003) 2060-2063
56. Israel R.A., Rosenberg H.M., and Curtin I.R. Analytical potential for multiple cause-of-death data. Am J Epidemiol 124 (1986) 161-179
57. Rosenberg H.M. Improving cause-of-death statistics. Am J Public Health 79 (1989) 563-564
58. Tan J.A., Joseph T.A., and Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology 48 (2008) 1387-1395
59. Salomon J.A., Weinstein M.C., Hammitt J.K., and Goldie S.J. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA 290 (2003) 228-237
60. Spaulding A.C., Weinbaum C.M., Lau D.T., Sterling R., Seeff L.B., Margolis H.S., et al. A framework for management of hepatitis C in prisons. Ann Intern Med 144 (2006) 762-769
61. Beck A.J., and Maruschak L.M. Hepatitis testing and treatment in state prisons. Bureau of Justice Statistics Special Report (NCJ 199173C) (2004), U.S. Department of Justice, Washington, DC
62. Mumola CJ. Substance abuse and treatment, state and federal prisoners, 1997. Bureau of Justice Statistics Special Report (NCJ 172871). Washington, DC: U.S. Department of Justice; 1999.